Content navigation
Key takeaways
- Third quarter of 2024 saw positive returns in emerging markets (EM)
- Coordinated stimulus announcement in China drove positive equity returns
- Technology stocks struggled amidst a weaker outlook for memory
- US Federal Reserve announced a larger-than-expected rate cut of 50 basis points
Market overview
EM performance in the third quarter saw a significant policy pivot from China with coordinated monetary, property, and equity market changes. EM witnessed near double-digit growth, driven by a >20% return in China.
Monetary policy easing in the US, where the Federal Reserve announced a 50 basis point rate cut, led to strong performance from the more interest rate sensitive countries in EM, such as those in Southeast Asia (Indonesia, Thailand, and Philippines). Korea and Taiwan were more muted, as we saw some consolidation in large-cap Asian technology stocks, which are concentrated in these markets.
Latin American markets were differentiated with reasonable performance coming out of Brazil (up 7%) versus Mexico, which was down 3% amid investor concerns following the passage of a controversial judicial reform.
MSCI EM sector performance Q3 2024 
Source: FactSet, as at 30 September 2024. Data in US$.
Top ten holdings by active weight
| Stock | Country | Sector | Portfolio(%) |
|---|---|---|---|
| Samsung Electronics | Korea | Information Technology | 6.4 |
| Tencent | China | Communication Services | 8.0 |
| HDFC Bank | India | Financials | 3.9 |
| ICICI Bank | India | Financials | 3.6 |
| SK Hynix | Korea | Information Technology | 3.5 |
| Titan | India | Consumer Discretionary | 2.7 |
| AIA | Hong Kong | Financials | 1.9 |
| Antofagasta | United Kingdom | Materials | 1.9 |
| WEG | Brazil | Industrials | 2.0 |
| China Merchants Bank | China | Financials | 1.9 |
Martin Currie as of 30 September 2024. Data shown is for the Martin Currie Global Emerging Markets representative account. Holdings are subject to change.
Portfolio discussion
Consumer discretionary was the most additive sector, driven by a combination of strong stock selection and asset allocation. In particular the broader strength in Chinese equities supported this, especially our holdings in this sector such as Meituan, JD.com and Alibaba, which benefitted from improving confidence following the stimulus announcements by the Chinese authorities. From a country perspective, China and Hong Kong were the most additive, driven by the broader equity rally and improved macroeconomic outlook. Although the stimulus announcement was late in the period, it was the higher quality part of the market which exhibited the most strength, leading overall to strong stock selection driving our Chinese/Hong Kong portfolio returns.
Our overweight to technology names was largely detractive from portfolio performance during the third quarter. While the year-to-date performance in this sector has been strong, there was weakness in Q3 especially within the semiconductor industry which has been impacted by dwindling sentiment in the overall memory market. The resultant profit taking was due to the weaker outlook. Key detractors from strategy performance in this sector included Samsung Electronics, SK Hynix, TSMC and Globalwafers. The concentration of technology and particularly held semiconductor stocks in Korea led to this being the most detractive country.
Portfolio activity
We added three companies to our clients’ portfolios:
PKO: An established banking leader in Poland with a return profile that has structurally improved following the digestion of Swiss Franc mortgages. Poland is benefitting from strong Gross Domestic Product (GDP) growth, loan growth, and benign asset quality. The bank is one of the best capitalised in the Central Eastern European region.
MediaTek: Fifth largest fabless semiconductor company in the world with a historical focus on the Chinese smartphone industry. The company is exposed to multiple long-term growth engines ranging from its exposure in enterprise ASIC, auto semiconductors, and finally a large-scale shift in the smartphone replacement cycle as a result of AI Edge.
Apollo Hospitals: India's largest hospital company and owner of the country’s largest branded pharmacy network. There are significant structural growth opportunities for hospitals in India, where there are just 0.5 beds per 1,000 population (vs. 4.2 in China and 2.1 in Thailand, for example).
We exited six companies during the period:
Credicorp: Unable to separate itself from the underlying economic performance of Peru, which has continued to disappoint on growth amid a challenging political backdrop. Ultimately, we feel there are better opportunities available and this position is a source of funding.
Naver: The companies growth profile is normalising from increased competition across its key product areas, most notably ecommerce and advertising. Capital allocation has been unclear following the appointment of a relatively inexperienced management team and the subsequent acquisition of Poshmark.
Orbia: The old-economy, developed-market business mix has been impacted by cyclical headwinds. Whilst the business could recover profitability from here, its fate lies with end market recovery rather than management direction. Although its valuation is undemanding, we believe there are better opportunities elsewhere.
PT Telkom Indonesia: Despite a prolonged period of rational competition and market consolidation, PT Telkom Indonesia has repeatedly failed to deliver the level of growth we had anticipated. On the mobile side, the monetisation of data has been largely offset by the continued decline in legacy revenues, while Indihome has reached saturation much quicker than we expected. From a portfolio perspective, the stock has also failed to deliver on its defensive characteristics.
Shanghai Fosun Pharmaceuticals: Fosun has a long track record of creating value by growing and spinning out healthcare businesses; however, in recent years its return on equity (ROE) has fallen to single digits and debt levels have risen (a decrease in quality characteristics). Management has also struggled to articulate a clear strategy to return the business to double-digit ROE.
Xinyi Solar: Oversupply in the solar module supply chain has left all companies vulnerable to any slowdown in demand growth. We believe demand will be challenged by bottlenecks in China's transmission network, leading to further price disruption across the supply chain.
Important Information
The information provided should not be considered a recommendation to purchase or sell any particular strategy / fund / security. It should not be assumed that any of the security transactions discussed here were or will prove to be profitable.
This information is issued and approved by Martin Currie Investment Management Limited (‘MCIM’), authorised and regulated by the Financial Conduct Authority. It does not constitute investment advice. Market and currency movements may cause the capital value of shares, and the income from them, to fall as well as rise and you may get back less than you invested.
The information contained in this document has been compiled with considerable care to ensure its accuracy. However, no representation or warranty, express or implied, is made to its accuracy or completeness. Martin Currie has procured any research or analysis contained in this document for its own use. It is provided to you only incidentally and any opinions expressed are subject to change without notice.
The document does not form the basis of, nor should it be relied upon in connection with, any subsequent contract or agreement. It does not constitute, and may not be used for the purpose of, an offer or invitation to subscribe for or otherwise acquire shares in any of the products mentioned.
Past performance is not a guide to future returns.
The distribution of specific products is restricted in certain jurisdictions, investors should be aware of these restrictions before requesting further specific information.
The views expressed are opinions of the portfolio managers as of the date of this document and are subject to change based on market and other conditions and may differ from other portfolio managers or of the firm as a whole. These opinions are not intended to be a forecast of future events, research, a guarantee of future results or investment advice.
Some of the information provided in this document has been compiled using data from a representative account. This account has been chosen on the basis it is an existing account managed by Martin Currie, within the strategy referred to in this document. Representative accounts for each strategy have been chosen on the basis that they are the longest running account for the strategy. This data has been provided as an illustration only, the figures should not be relied upon as an indication of future performance. The data provided for this account may be different to other accounts following the same strategy. The information should not be considered as comprehensive and additional information and disclosure should be sought.
The information provided should not be considered a recommendation to purchase or sell any particular strategy / fund / security. It should not be assumed that any of the securities discussed here were or will prove to be profitable.
It is not known whether the stocks mentioned will feature in any future portfolios managed by Martin Currie. Any stock examples will represent a small part of a portfolio and are used purely to demonstrate our investment style.
Risk warnings – Investors should also be aware of the following risk factors which may be applicable to the strategy shown in this document.
- Investing in foreign markets introduces a risk where adverse movements in currency exchange rates could result in a decrease in the value of your investment.
- This strategy may hold a limited number of investments. If one of these investments falls in value this can have a greater impact on the strategy’s value than if it held a larger number of investments.
- Smaller companies may be riskier and their shares may be less liquid than larger companies, meaning that their share price may be more volatile.
- Emerging markets or less developed countries may face more political, economic or structural challenges than developed countries. Accordingly, investment in emerging markets is generally characterised by higher levels of risk than investment in fully developed markets.
- The strategy may invest in derivatives Index futures and FX forwards to obtain, increase or reduce exposure to underlying assets. The use of derivatives may result in greater fluctuations of returns due to the value of the derivative not moving in line with the underlying asset. Certain types of derivatives can be difficult to purchase or sell in certain market conditions.
For wholesale investors in Australia:
This material is provided on the basis that you are a wholesale client. MCIM has entered an Intermediary arrangement with Franklin Templeton Australia Limited (ABN 76 004 835 849) (AFSL No. 240827) (FTAL) to facilitate the provision of financial services by MCIM to wholesale investors in Australia. Franklin Templeton Australia Limited is part of Franklin Resources, Inc., and holds an Australian Financial Services Licence (AFSL No. AFSL240827) issued pursuant to the Corporations Act 2001.
For professional investors in Canada.
This material is intended for residents in, or incorporated in, Canada and are a Permitted Client for the purposes of MI 31-103. The information on this section of the website is not intended for use by any other person, including members of the public.
Martin Currie Inc, incorporated in New York with its registered office at 280 Park Avenue, New York, NY 10017 and having a UK branch registered in Scotland (no SF000300), Head office, 5 Morrison Street, 2nd floor, Edinburgh, EH3 8BH, Tel: +44 (0) 131 229 5252 Fax: +44 (0) 131 222 2532 www.martincurrie.com, operates under the International Adviser Exemption with the Ontario Securities Commission (‘OSC’) and is therefore currently not required to be registered as a portfolio manager for the purposes of MI 31-103. Martin Currie Inc. is also authorised by the UK Financial Conduct Authority.
For the avoidance of doubt, nothing excludes, limits or restricts our obligations to you under the UK Financial Services and Market Act 2000, National Instruments or any other applicable law or regulation.
The opinions and views in this website do not take into account your individual circumstances, objectives, or needs and are not intended to be recommendations of particular financial instruments or strategies to you.
This website does not identify all the risks (direct or indirect) or other considerations which might be material to you when entering any financial transaction. You should consult with your professional advisers before undertaking any investment activity. The information provided on this website should not be treated as advice or a recommendation to buy or sell any particular security or other investment. The information on this website has not been reviewed by any competent regulatory authority.
For professional investors:
In the People’s Republic of China:
This document does not constitute a public offer of the strategy, whether by sale or subscription, in the People’s Republic of China (the “PRC”). These strategies are not being offered or sold directly or indirectly in the PRC to or for the benefit of, legal or natural persons of the PRC.
Further, no legal or natural persons of the PRC may directly or indirectly purchase any of the strategy or any beneficial interest therein without obtaining all prior PRC’s governmental approvals that are required, whether statutorily or otherwise. Persons who come into possession of this document are required by the issuer and its representatives to observe these restrictions.
In Hong Kong:
The contents of this document have not been reviewed by any regulatory authority in Hong Kong. You are advised to exercise caution in relation to the offer. If you are in any doubt about any of the contents of this document, you should obtain independent professional advice.
In South Korea:
This document is for information purposes only. It is prepared and presented to provide an introduction to the business of MCIM and its related companies (collectively known as ‘Martin Currie’). This document does not constitute an offer to sell or a solicitation of any offer to invest in any security, fund or other vehicle managed or advised by Martin Currie.
None of the security(ies), fund(s) or vehicle(s) managed by or advised by Martin Currie are registered in South Korea under the Financial Investment Services and Capital Markets Act of Korea and accordingly, none of these instruments nor any interest therein may be offered, sold or delivered, or offered or sold to any person for re-offering or resale, directly or indirectly, in South Korea or to any resident of South Korea except pursuant to applicable laws and regulations of South Korea.
Martin Currie is not registered with or regulated by any regulatory authorities in South Korea.